# The Amplification Framework

> The Amplification Framework is a three-component model of supplement and nootropic design proposed by Rev. Ryan Sasha-Shai Van Kush in September 2021 (Plant Medicine for Humans: L-MethylFolate,…

Canonical: https://wiki.soapbox.community/wiki/The_Amplification_Framework
Section: Substances and pharmacology
Last updated: 2026-10-20
Publisher: Library of Ashurbanipal (Van Kush Family Research Institute), https://wiki.soapbox.community

**The Amplification Framework** is a three-component model of supplement and nootropic design proposed by Rev. Ryan Sasha-Shai Van Kush in September 2021 (*Plant Medicine for Humans: L-MethylFolate*, Blurt/@punicwax, 18 September 2021) and expanded in the Institute's February 2026 revision.

Its claim is that optimal synthesis of a target molecule requires not one active agent but **three functional roles filled at once**.

## The three components

{| class="wikitable"
! Role !! Function !! Monoamine example
|-
| **1. Substrate provider** || supplies the raw molecular input || L-tryptophan, L-tyrosine, L-phenylalanine
|-
| **2. Cofactor amplifier** || regenerates or supplies the cofactor that activates the enzyme || **L-Methylfolate** — regenerates BH4 via the salvage pathway
|-
| **3. Degradation inhibitor** || prevents breakdown of the product or the cofactor || vitamin C (reduces the BH3 radical back to BH4); antioxidants
|}

## How it was arrived at

By noticing a structural parallel. The **cholinergic** stack is long established in nootropic practice, and it has exactly this shape:

{| class="wikitable"
! Role !! Cholinergic stack (established) !! Monoamine stack (proposed)
|-
| Substrate || **alpha-GPC** — choline source || L-tryptophan / L-tyrosine
|-
| Modulator || **piracetam / phenylpiracetam** — receptor sensitiser || **L-Methylfolate** — BH4 cofactor regeneration
|-
| Degradation inhibitor || acetylcholinesterase inhibitors, antioxidants || vitamin C, L-carnosine
|}

The framework's assertion is that the monoamine column had a hole in the modulator row, and that L-methylfolate fills it.

## Why this is the same idea as the cannabinoid work

The Cannabinoid Oilahuasca framework is the **degradation-inhibitor** row taken on its own and pursued to its conclusion: rather than supplying an agonist, inhibit MAGL and FAAH so that the ligand the body already makes persists longer. The classical ayahuasca combination — DMT plus an MAO inhibitor — is the same structure again, one row of substrate and one of degradation inhibitor. The Amplification Framework is the general statement of which those are instances.

## Extended application

The paper proposes that L-methylfolate's efficacy is optimised alongside amino-acid substrates (L-tyrosine, L-phenylalanine, L-tryptophan), cofactor support (B12, B6, B2, iron), antioxidant protection (vitamin C, L-carnosine) and neuroprotective agents (astragalus / cycloastragenol).

## Status

**This is an independent theoretical contribution, not an established model.** The individual mechanisms it composes are published; the framework itself is the author's, and the specific claim that filling all three roles outperforms filling one has not been tested in a trial. It is a design heuristic with a clear rationale, and it should be read as that.

See also: L-Methylfolate · Racetams · Choline Donors · Cannabinoid Oilahuasca · Stack Substances